First Treatment Approved for Chronic Rhinosinusitis Without Nasal Polyps
(MedPage Today) -- The FDA expanded the approval of fluticasone propionate (Xhance) nasal spray for chronic rhinosinusitis to also include treatment of adults without nasal polyps, manufacturer Optinose announced on Friday.
The drug-device combination... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - March 19, 2024 Category: Allergy & Immunology Source Type: news
Exhalation Delivery System With Fluticasone Effective for Rhinosinusitis
FRIDAY, Jan. 26, 2024 -- For patients with chronic rhinosinusitis (CRS), an exhalation delivery system that delivers fluticasone (EDS-FLU) to sinonasal areas above the inferior turbinate is efficacious, irrespective of nasal polyps, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 26, 2024 Category: Pharmaceuticals Source Type: news
Flovent Discontinuation in 2024 Raises Concerns for Doctors, Patients
FRIDAY, Dec. 29, 2023 -- In a move that is causing concern among doctors and patients, GlaxoSmithKline is discontinuing Flovent (fluticasone inhalation) as of Jan. 1, 2024.The pharmaceutical company will make " an authorized generic " version of the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 29, 2023 Category: Pharmaceuticals Source Type: news
Long-Acting Steroid Gives 14 Weeks of Knee OA Relief
(MedPage Today) -- SAN DIEGO -- A novel extended-release formulation of fluticasone propionate provided long-lasting symptom improvement with a single injection in patients with knee osteoarthritis (OA), according to a phase II study presented... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - November 13, 2023 Category: Rheumatology Source Type: news
Fluticasone Furoate Does Not Cut Time to COVID-19 Symptom Resolution
THURSDAY, Sept. 21, 2023 -- For outpatients with mild-to-moderate COVID-19, inhaled fluticasone furoate does not shorten time to symptom resolution, according to a study published in the Sept. 21 issue of the New England Journal of Medicine.
David... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 21, 2023 Category: Pharmaceuticals Source Type: news
Inhaled Glucocorticoid Flops for Speeding COVID Recovery in Outpatients
(MedPage Today) -- Inhaled fluticasone furoate failed to shorten recovery time for non-hospitalized adults with COVID-19, new data from the adaptive ACTIV-6 trial found.
When used daily for 2 weeks, a quicker COVID-19 recovery time -- considered... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - September 21, 2023 Category: Infectious Diseases Source Type: news
Drug stores will start selling Narcan over the counter next week
For the first time, people across the US will soon be able to purchase an overdose-reversal drug that’s as easy to administer as Flonase, without a prescription. Next week, nationwide chains like Walgreens, CVS, Walmart, and Rite Aid will begin selling two-dose boxes of Narcan, a naloxone nasal…#flonase #cvs #walmart #riteaid #narcan #medicaid #medicare #missouri #massachusetts #rhodeisland (Source: Reuters: Health)
Source: Reuters: Health - August 30, 2023 Category: Consumer Health News Source Type: news
Generic, Brand-Name Medication Similarly Effective for COPD
MONDAY, Aug. 7, 2023 -- For patients with chronic obstructive pulmonary disease (COPD), generic and brand-name fluticasone-salmeterol are similarly effective and safe, according to a study published online Aug. 8 in the Annals of Internal... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 7, 2023 Category: Pharmaceuticals Source Type: news
Generic Fluticasone –Salmeterol Inhaler for COPD Matches Branded Product
(MedPage Today) -- A generic fluticasone-salmeterol (Wixela Inhub) maintenance inhaler was clinically equivalent to name-brand Advair Diskus for chronic obstructive pulmonary disease (COPD), a propensity score-matched cohort study found.
With... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - August 7, 2023 Category: Primary Care Source Type: news
Fluticasone Delivery System Reduced Exacerbations of Chronic Rhinosinusitis
(MedPage Today) -- WASHINGTON -- Use of an exhalation delivery system with fluticasone (EDS-FLU; Xhance) significantly reduced acute exacerbations of chronic rhinosinusitis, which may drive down the need for antibiotics, an analysis of two randomized... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - October 24, 2022 Category: Infectious Diseases Source Type: news
Asthma Drug Fluticasone Fails as Potential COVID-19 Treatment
THURSDAY, July 14, 2022 -- The asthma drug fluticasone furoate is yet another medication that does not work for mild-to-moderate COVID-19, a new study finds. The study was published online July 13 in medRxiv, which publishes studies before they have... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 14, 2022 Category: Pharmaceuticals Source Type: news
Asthma Drug Fluticasone Furoate Fails as Potential COVID Treatment
THURSDAY, July 14, 2022 -- The asthma drug fluticasone furoate is yet another medication that doesn ' t work for mild-to-moderate COVID-19, a new study finds. " There was no evidence of improvement in time to recovery or reduction in hospitalizations... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 14, 2022 Category: General Medicine Source Type: news
ArmonAir Digihaler (Fluticasone Propionate Powder for Inhalation) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 10, 2022 Category: Drugs & Pharmacology Source Type: news
Flovent (Fluticasone Propionate) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 17, 2021 Category: Drugs & Pharmacology Source Type: news
ArmonAir RespiClick (fluticasone propionate)
Title: ArmonAir RespiClick (fluticasone propionate)Category: MedicationsCreated: 10/9/2020 12:00:00 AMLast Editorial Review: 10/9/2020 12:00:00 AM (Source: MedicineNet Asthma General)
Source: MedicineNet Asthma General - October 9, 2020 Category: Respiratory Medicine Source Type: news
